Outlook Therapeutics, Inc. research brief

CIK 1649989 Copy CIK

Generated Nov. 2, 2026, 6:41 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: ISELIN NJ. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• May 7, 2026 · D · 0001231919-26-000465 · Source evidence

  Reported offering amount: 5000000 USD. Reported amount sold: 0 USD.

• Jan. 27, 2025 · D · 0001231919-25-000018 · Source evidence

  Reported offering amount: 31977359 USD. Reported amount sold: 0 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Outlook Therapeutics, Inc. research brief,” CIK 1649989, retrieved Nov. 2, 2026, 6:41 p.m.. Cite the specific accessions used. No amounts have been summed.